IP Library › Assignment 044351/0408
Patent Assignment
Reel/Frame 044351/0408

Confirmatory License

Recorded: 2017-11-02 Pages: 2
Assignor
UNIVERSITY OF MINNESOTA
Executed: 2017-10-31
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property (1)
Methods to Treat Mucopolysaccharidosis Type Ii or Deficiency in Iduronate-2-Sulfatase Using a Recombinant Adeno-Associated Virus (Aav) Vector Encoding Iduronate-2-Sulfatase
Application: 15/717,358 →
Publication: US 2018/0099030
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 15, 2017
From: KOZARSKY, KAREN, PH.D
To: REGENXBIO INC.
Reel/Frame 044405/0435 →
Assignment of Assignor's Interest Dec 15, 2017
From: MCIVOR, R. SCOTT; BELUR, LALITHA R.; LOW, WALTER; FAIRBANKS, CAROLYN
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 044405/0603 →
Assignment of Assignor's Interest Jul 7, 2025
From: REGENXBIO INC.
To: REGENXBIO RS LLC
Reel/Frame 071840/0471 →